The field of immunometabolism is a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.
Changes to these pathways are pivotal in the development of severe diseases, including autoimmune conditions and cancer.
Immunometabolic therapies offer complementary and highly differentiated approaches to treating disease by correcting immune cell function and/or inhibiting tumour cell growth.
Globally renowned scientific founders and a highly experienced team
Focus on the emerging interface between immunologic function and metabolism
A US $880 million validating collaboration with Eli Lilly
Building a diverse pipeline of first in class small molecule, oral candidates in immunology and oncology
An imbalance of the immune system exists in autoimmune diseases and cancer.
Metabolic pathways drive the functional identity of cells of the immune system.
The balance of the system can be impacted by modulating the metabolism of immune cells and vice versa.